FRISCO,
Texas, July 30, 2024 /PRNewswire/ -- Baird
Medical Devices, Inc. ("Baird Medical"), a leading developer and
provider of microwave ablation ("MWA") medical devices in
China and the United States, today announced a
cross-market engagement and education program designed at fostering
both knowledge and awareness of thyroid Microwave Ablation
Technology. Baird Medical both hosts and participates in a range of
programs over the course of the year to facilitate the safe
development of the industry.
It is critically important to understand what makes MWA a
preferred choice to radio frequency ablation as a procedure. There
are numerous benefits for both patient and physician addressing
both safety and aesthetic appearance. However, awareness of the key
differences and the implementation of the procedure are still
relatively low. This has led to Baird Medical developing a unique
program of engagement and education about this new therapy.
"Regardless of where we develop our business, fostering
meaningful relationships that contribute to industry excellence in
microwave ablation is where we want to be," said Ms. Haimei Wu,
Founder and CEO of Baird Medical. "We are delighted to play a role
in convening leading medical experts to drive meaningful progress
in addressing any misconceptions as well as ensuring safe and
efficient use of this innovative medical technology."
Baird Medical hosts the third Global Thyroid Microwave
Ablation Technology Exchange Conference
On July 25th, Baird
Medical hosted the third Global Thyroid Microwave Ablation
Technology Exchange Conference. This event drew together
distinguished industry experts from both the United States and China to share their knowledge and experience
during the event. From China,
several luminaries gave talks including Dr. Xiaoqing Pei from the
Sun Yat-sen University Cancer Center; Dr. Chenfang Zhu from The Ninth People's Hospital
affiliated to Shanghai Jiaotong University School of Medicine; and,
Dr. Yunjun Wang from Fudan
University Shanghai Cancer Center.
Numerous esteemed experts from the
United States also joined the conference and participated in
the dialogue, including Dr. Alireza
Falahati from Utah Endocrinology Associates; Dr.
Jennifer Hong Kuo from Columbia University Irving Medical Center; Dr.
Toni Beninato from Rutgers Cancer
Institute; Dr. Kepal N. Patel from
NYU Langone Hospitals; Dr. Iheoma
Nwaogu from El Camino Health – Mountain View Hospital; Dr.
Gary G. Tse from UCLA Radiology
Medical Group; Dr. Melanie Goldfarb
from Providence Saint John's Health Center; Dr. Gregory W. Randolph from Harvard Medical School; Dr. Stephanie L. Lee from Boston Medical Center; Dr. Jagdish. K.
Dhingra from BethIsrael Deaconess Medical Center; Dr. Julia E. Noel from Sandford Medicine; and, Dr. Ashok R. Shaha from Memorial Sloan Ketterinc
Cancer Center.
The comprehensive educational exchange delved into various
aspects of managing thyroid growth, addressing a range of topics
from application and preparation to technical modifications and
essentials for safe and effective microwave ablation of benign
thyroid nodules. The conference also showcased hands-on procedures
and techniques for safe and effective ablation work.
Baird Medical joins Greater Bay Area Medical Device
Conference & 61st Medical Device Consumables Resource Expo in
China
On June 26th, Baird
Medical's General Manager, Mr. Hou
Wei, joined the Greater Bay Area Medical Device Conference
& 61st Medical Device Consumables Resource Expo in
Guangzhou, China. The event
brought together a diverse group of experts and professionals from
China's medical device and
healthcare sectors.
During the conference, Mr. Hou gave an informative presentation
on Microwave Ablation Technology. He specifically highlighted the
technology's use in thyroid treatments and discussed the
significant role it can play in shaping the future of healthcare in
China.
Baird Medical is headquartered in Guangzhou, a major city in Southern China which sits at the apex of
China's Greater Bay Area, an area
encompassing several cities and hubs across Guangdong province, Macao and Hong
Kong that are critical to China's future growth strategy in
innovation.
About Baird Medical
Established in 2012 and headquartered in Guangzhou, China, Baird Medical is a leading
microwave ablation (MWA) medical device manufacturer and provider
in China and the United States. Baird Medical's proprietary
medical devices are used for the treatment of benign and malignant
tumors including thyroid nodules, liver cancer, lung cancer and
breast lumps. Baird Medical is the first company to obtain a Class
III medical devices registration certificate for MWA medical
devices specifically indicated for thyroid nodules in China. For more information, please visit
http://baidesz.com/.
Contacts
Investor Relations
Robin Yang, Partner
ICR, LLC
Phone: +1 (646) 308-1475
Email: BairdMedical.IR@icrinc.com
Public Relations
Brad Burgess, Senior Vice
President
ICR, LLC
Phone: +1 (646) 588-0383
Email: BairdMedical.PR@icrinc.com
View original
content:https://www.prnewswire.com/news-releases/baird-medical-announces-engagement-and-education-program-for-the-development-of-thyroid-microwave-ablation-technology-302209543.html
SOURCE Baird Medical Devices, Inc.